Eleven Biotherapeutics, Inc. (EBIO) - NASDAQ
From other sites
Company Description
Eleven Biotherapeutics, Inc. is a biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it apply to the discovery and development of protein therapeutics to treat diseases of the eye. Its therapeutic approach is based on the role of cytokines in diseases... More
Sector: Healthcare
Industry: Biotechnology
Country: United States